Chung Hang Jonathan Choi
Chung Hang Jonathan Choi
Assistant Dean (Student Affairs), Faculty of Engineering, The Chinese University of Hong Kong
Verified email at - Homepage
Cited by
Cited by
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
ME Davis, JE Zuckerman, CHJ Choi, D Seligson, A Tolcher, CA Alabi, ...
Nature 464 (7291), 1067-1070, 2010
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
CHJ Choi, CA Alabi, P Webster, ME Davis
Proceedings of the National Academy of Sciences 107 (3), 1235-1240, 2010
Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
CHJ Choi, L Hao, SP Narayan, E Auyeung, CA Mirkin
Proceedings of the National Academy of Sciences 110 (19), 7625-7630, 2013
Targeting kidney mesangium by nanoparticles of defined size
CHJ Choi, JE Zuckerman, P Webster, ME Davis
Proceedings of the National Academy of Sciences 108 (16), 6656-6661, 2011
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
JE Zuckerman, CHJ Choi, H Han, ME Davis
Proceedings of the National Academy of Sciences 109 (8), 3137-3142, 2012
A general approach to DNA-programmable atom equivalents
C Zhang, RJ Macfarlane, KL Young, CHJ Choi, L Hao, E Auyeung, G Liu, ...
Nature Materials 12 (8), 741-746, 2013
Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements
T Schluep, J Hwang, IJ Hildebrandt, J Czernin, CHJ Choi, CA Alabi, ...
Proceedings of the National Academy of Sciences 106 (27), 11394-11399, 2009
Intracellular Fate of Spherical Nucleic Acid Nanoparticle Conjugates
XA Wu, CHJ Choi, C Zhang, L Hao, CA Mirkin
Journal of the American Chemical Society 136 (21), 7726–7733, 2014
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
GJ Weiss, J Chao, JD Neidhart, RK Ramanathan, D Bassett, JA Neidhart, ...
Investigational new drugs 31 (4), 986-1000, 2013
A Gold@Polydopamine Core–Shell Nanoprobe for Long-Term Intracellular Detection of MicroRNAs in Differentiating Stem Cells
CKK Choi, J Li, K Wei, YJ Xu, LWC Ho, M Zhu, KKW To, CHJ Choi, L Bian
Journal of American Chemical Society 137 (23), 7337–7346, 2015
Transitioning DNA‐Engineered Nanoparticle Superlattices from Solution to the Solid State
E Auyeung, RJ Macfarlane, CHJ Choi, JI Cutler, CA Mirkin
Advanced Materials 24 (38), 5181-5186, 2012
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth
MA Rahman, ARMR Amin, X Wang, JE Zuckerman, CHJ Choi, B Zhou, ...
Journal of controlled release 159 (3), 384-392, 2012
Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents
AH Alhasan, PC Patel, CHJ Choi, CA Mirkin
Small 10 (1), 186-192, 2014
A crosslinked nucleic acid nanogel for effective siRNA delivery and antitumor therapy
F Ding, Q Mou, Y Ma, G Pan, Y Guo, G Tong, CHJ Choi, X Zhu, C Zhang
Angewandte Chemie International Edition 57 (12), 3064-3068, 2018
The Sequence-Specific Cellular Uptake of Spherical Nucleic Acid Nanoparticle Conjugates
SP Narayan, CHJ Choi, L Hao, CM Calabrese, A Evelyn, C Zhang, ...
Small 11 (33), 4173–4182, 2015
Mechanism for the cellular uptake of targeted gold nanorods of defined aspect ratios
H Yang, Z Chen, L Zhang, WY Yung, KCF Leung, HYE Chan, CHJ Choi
Small 12 (37), 5178-5189, 2016
Biodegradable DNA‐Brush Block Copolymer Spherical Nucleic Acids Enable Transfection Agent‐Free Intracellular Gene Regulation
C Zhang, L Hao, CM Calabrese, Y Zhou, CHJ Choi, H Xing, CA Mirkin
Small 11 (40), 5360-5368, 2015
Recent advances in managing atherosclerosis via nanomedicine
CKW Chan, L Zhang, CK Cheng, H Yang, Y Huang, XY Tian, CHJ Choi
Small 14 (4), 1702793, 2018
Oligonucleotide flexibility dictates crystal quality in DNA‐programmable nanoparticle superlattices
AJ Senesi, DJ Eichelsdoerfer, KA Brown, B Lee, E Auyeung, CHJ Choi, ...
Advanced Materials 26 (42), 7235-7240, 2014
Micellar delivery of dasatinib for the inhibition of pathologic cellular processes of the retinal pigment epithelium
Q Li, KL Lai, PS Chan, SC Leung, HY Li, Y Fang, KKW To, CHJ Choi, ...
Colloids and surfaces B: biointerfaces 140, 278-286, 2016
The system can't perform the operation now. Try again later.
Articles 1–20